Ocuphire Pharma, Inc. (OCUP) Stock Analysis
DELISTED 2024
What happened to Ocuphire Pharma, Inc. (OCUP) stock?
Ocuphire Pharma, Inc. (OCUP) no longer trades on public markets. It was delisted in October 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2024
- Last recorded price (historical):
- $1.17 (last quote on record before the October 2024 delisting; historical, not a current quote)
Market cap $31.7M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ocuphire Pharma, Inc. (OCUP). Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for refractive and retinal eye disorders. Their lead product candidate, Nyxol eye drops, is undergoing Phase III clinical trials.
Last analyzed: Mar 17, 2026Ocuphire Pharma, Inc. (OCUP) Healthcare & Pipeline Overview
More about this archive record
Can I still buy OCUP shares?
No. OCUP stopped trading on public markets in October 2024, so the shares are not available through a broker. Anything you see quoted for OCUP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OCUP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ocuphire Pharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.